In the original article, we overlooked to acknowledge the funder National Research Foundation, Singapore, NRF-NRFI-2015-007 to Kanaga Sabapathy.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
Summary
Keywords
dominant-negative effect, gain-of-functions, mutant p53-addiction, oncogene, p53, tumor-suppressor
Citation
Sabapathy K (2021) Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions. Front. Oncol. 11:665504. doi: 10.3389/fonc.2021.665504
Received
08 February 2021
Accepted
09 February 2021
Published
31 March 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2021
Updates
Copyright
© 2021 Sabapathy.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kanaga Sabapathy cmrksb@nccs.com.sg
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.